Skip to content

Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1 Patients

Assessment of the Neurovascular Microcirculatory Response in Diabetes Type 1

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02538120
Acronym
NEURODIAB1
Enrollment
40
Registered
2015-09-02
Start date
2012-05-31
Completion date
2015-09-30
Last updated
2016-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 1

Brief summary

This study aims to see whether or not the diabetes 1 patients have a neurovascular microcirculatory dysfunction using various microvascular tests which have been previously validated. Microvascular responses will be assessed by Laser Speckle Contrast Imaging and expressed in Laser Speckle Perfusion Units (LSPU).

Detailed description

The investigators will compare microvascular responses between diabetes type 1 patients with matched control-subjects.

Interventions

Microvascular assessment

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Diabetes type 1 patients * Matched control-subjects

Exclusion criteria

* Patients or subjects with anti-inflammatory drugs

Design outcomes

Primary

MeasureTime frameDescription
Neurovascular microcirculatory responseone dayNeurovascular response will be assessed by laser speckle contrast imaging using various microvascular tests such as deionized water iontophoresis, local heating test. Results will be explained in Laser Speckle Perfusion Units (LSPU)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026